Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 16.98% is in line with its 5-year average of 16.57%, around the middle of its 5-year range (13.02%–25.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.01% below its 12-month average of 17.50%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
16.98%
EBITDA MARGIN AVG TTM
17.50%
EBITDA MARGIN AVG 3Y
16.05%
EBITDA MARGIN AVG 5Y
16.57%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.01%
CURRENT VS 3Y AVG
+5.75%
CURRENT VS 5Y AVG
+2.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
GE HealthCare Technologies Inc.
Market Cap
$33.24B
EBITDA Margin
16.98%
TTM Avg
17.50%
3Y Avg
16.05%
5Y Avg
16.57%
Market Cap
$30.80B
EBITDA Margin
34.73%
TTM Avg
34.58%
3Y Avg
34.05%
5Y Avg
33.84%
Market Cap
$30.42B
EBITDA Margin
15.00%
TTM Avg
4.83%
3Y Avg
-18.55%
5Y Avg
-52.26%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $33.24B | 16.98% | 17.50% | 16.05% | 16.57% |
| Centene Corp. (CNC)vs › | $33.15B | -3.26% | -0.27% | 1.02% | 1.75% |
| ResMed Inc. (RMD)vs › | $32.61B | 36.98% | 37.16% | 34.64% | 34.36% |
| DexCom, Inc. (DXCM)vs › | $34.03B | 24.96% | 22.62% | 21.42% | 19.95% |
| Zoetis Inc. (ZTS)vs › | $31.25B | 43.14% | 42.58% | 42.20% | 41.87% |
| Biogen Inc. (BIIB)vs › | $30.95B | 28.67% | 30.68% | 30.30% | 31.44% |
| Waters Corporation (WAT)vs › | $30.80B | 34.73% | 34.58% | 34.05% | 33.84% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $30.42B | 15.00% | 4.83% | -18.55% | -52.26% |
| Medline Inc. (MDLN)vs › | $30.26B | 10.26% | 11.41% | 10.38% | 10.38% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.51B | 30.90% | 31.59% | 31.63% | 30.80% |
Gross Margin
42.9%
EBITDA Margin
17.0%
Operating Margin
12.7%
Net Margin
7.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 16.98% |
| 2026-03-31 | 13.02% |
| 2025-12-31 | 25.93% |
| 2025-09-30 | 15.57% |
| 2025-06-30 | 16.02% |
| 2025-03-31 | 16.01% |
| 2024-12-31 | 17.69% |
| 2024-09-30 | 16.84% |
| 2024-06-30 | 15.64% |
| 2024-03-31 | 14.80% |
| 2023-12-31 | 16.00% |
| 2023-09-30 | 15.97% |
| 2023-06-30 | 15.07% |
| 2023-03-31 | 15.21% |
| 2022-12-31 | 18.91% |
| 2022-09-30 | 16.72% |
| 2022-06-30 | 17.57% |
| 2022-03-31 | 15.38% |
| 2021-12-31 | 19.20% |
| 2021-09-30 | 18.77% |
| 2021-06-30 | 19.93% |
| 2021-03-31 | 19.93% |
